Wei Wang
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 41
-
- Advanced biosensing and bioanalysis techniques 42
- Co-authors
- Pengfei Rong (70 shared papers)Frank M. Torti (3 shared papers)Suzy V. Torti (3 shared papers)Lan Gardner Coffman (1 shared paper)Mary Ann Knovich (1 shared paper)Zhichao Feng (20 shared papers)Xiaoqian Ma (25 shared papers)Xiang‐Yang Wang (3 shared papers)
- Journals
- PLoS ONE (18 papers)Scientific Reports (13 papers)Frontiers in Immunology (11 papers)Oncotarget (11 papers)Frontiers in Oncology (11 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Wang
943 papers receiving 28.5k citations
Wei Wang's Hit Papers
Peers
Comparison fields: 5 of 216
- Cancer Research 3.4k
- Infectious Diseases 2.5k
- Biomaterials 1.7k
- Molecular Biology 8.5k
- Oncology 2.8k
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.0k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism Hit paper breakdown → | 2012 | 1655 |
| 2 | Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US Hit paper breakdown → | 2020 | 727 |
| 3 | Serum ferritin: Past, present and future Hit paper breakdown → | 2010 | 699 |
| 4 | 2020 | 643 | |
| 5 | Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus Hit paper breakdown → | 2020 | 465 |
| 6 | 2018 | 421 | |
| 7 | 2010 | 391 | |
| 8 | 2016 | 327 | |
| 9 | 2014 | 291 | |
| 10 | 2014 | 280 | |
| 11 | Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles Hit paper breakdown → | 2024 | 217 |
| 12 | 2018 | 213 | |
| 13 | 2020 | 211 | |
| 14 | 2020 | 208 | |
| 15 | 2014 | 205 | |
| 16 | 2014 | 204 | |
| 17 | 2004 | 204 | |
| 18 | 2014 | 203 | |
| 19 | 2018 | 190 | |
| 20 | 2008 | 189 |
About Wei Wang
Wei Wang is a scholar working on Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cognitive Neuroscience and Surgery, having authored 1.0k papers that have together received 29.2k indexed citations. Recurring topics across this work include Functional Brain Connectivity Studies (69 papers), Nanoplatforms for cancer theranostics (48 papers), Advanced biosensing and bioanalysis techniques (42 papers), Cancer, Hypoxia, and Metabolism (41 papers), COVID-19 Clinical Research Studies (37 papers), Nanoparticle-Based Drug Delivery (35 papers), Pancreatic function and diabetes (34 papers) and Advanced Neuroimaging Techniques and Applications (28 papers). The work is most often cited by research in Cancer Research (3.4k citations), Infectious Diseases (2.5k citations), Biomaterials (1.7k citations), Molecular Biology (8.5k citations) and Oncology (2.8k citations). Wei Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Pengfei Rong, Frank M. Torti, Suzy V. Torti, Lan Gardner Coffman, Mary Ann Knovich, Zhichao Feng, Xiaoqian Ma, Xiang‐Yang Wang, Xianjun Fang and Zhuang Xue. Their work appears in journals such as PLoS ONE, Scientific Reports, Frontiers in Immunology, Oncotarget and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.